WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: CDAD Efficacy Endpoints v2-1, CDAD Medication Required has option -Yes -No, Toxin A/B Test has result -Toxin A Positive -Toxin B Positive -Negative, Global Cure is composite of Clinical Cure, Covariates includes Concomitant Antibacterial Treatment during study, Unformed Stool Count for 2 consecutive days has value -Integer Count (per day), Clinical Outcome at EOT assessed from CDAD Medication Required, History of CDAD has option -Yes -No, Clinical Outcome at EOT assessed from Signs and Symptoms, Clinical Outcome at Post Study Visit assessed from Toxin A/B Test, Covariates includes CDAD Baseline Disease Severity, Covariates includes C. Difficle Strain Virulence, Hospitalization has option -Inpatient -Outpatient, Concomitant Antibacterial Treatment during study has option -Yes -No, Clinical Cure derived from Clinical Outcome at EOT, Covariates includes Hospitalization, CDAD Efficacy Endpoints includes Global Cure, Recurrence derived from Clinical Outcome at Post Study Visit, Clinical Outcome at EOT assessment result -Cured, Clinical Outcome at Post Study Visit assessed from CDAD Medication Required, CDAD Medication Required has option -Yes -No